| abstract |
Muscarinic acetylcholine receptor antagonists and methods of using them for the treatment of muscarinic acetylcholine receptor mediated diseases, such as lung diseases, are provided. The present invention provides compounds useful for treating muscarinic acetylcholine receptor (mAChR) mediated diseases, and methods of treatment, wherein the method comprises an effective amount of a steric compound of formula (I) or formula (II). Administration of a chemically pure compound. The invention also relates to compounds that inhibit the binding of acetylcholine to its receptor. The invention also relates to a method for inhibiting the binding of acetylcholine to its receptor in a subject in need thereof, wherein said subject comprises an effective amount of a stereochemically pure compound of formula (I) or formula (II). Administration of a compound. [Selection] Figure 2 |